Company: PBH
Filing Date: 2025-06-27
Form Type: DEF 14A
Source: 0001295947-25-000021
Chunk: 14

Company: Prestige Consumer Healthcare Inc.
Filing Date: 2025-06-27
Form: DEF 14A
Chunk 14
---
 withoutmanagement present.                                                                                               |
| Board and Committee Self-Evaluations.The Board and each of its committees conducts a self-evaluation of its performance on an annual basis, with individualassignment and follow-up for any items identified as a part ofcontinuous improvement efforts. |

| No Overboarding.Non-employee directors are limited to no more than four publiccompany boards in addition to the Company, and the CEO islimited to one board in addition to the Company.                                       |
| Director Access and Resources.Board members have significant interaction with and directaccess to senior business leaders and outside experts.                                                                                |
| Stockholder Rights.Stockholders may act by written consent.                                                                                                                                                                   |
| Regular Review of Key Governance Documents.Annual review of Committee Charters, Corporate GovernanceGuidelines and Code of Conduct and Ethics.                                                                                |
| Robust Code of Conduct and Ethics.Code of Conduct and Ethics promotes honest and ethicalconduct throughout the Company and all employees receive                                                                              |
| Robust Risk Management Oversight.The Board and designated committees exercise oversight ofmanagement’s risk assessment and management processesand findings and oversee the Corporate Responsibility strategyand initiatives. |

| 24 |     | 2025 Proxy Statement | Prestige Consumer Healthcare Inc. |

Our Governance

Board Leadership Structure and Composition Ronald M. Lombardi serves as Chair of the Board, and John E. Byom currently serves as the Lead Independent Director. The Board of Directors currently has three standing committees: Audit and Finance Committee, Compensation and Talent Management Committee and Nominating and Corporate Governance Committee. Board of Director Practice Highlights

| Annual Election of Directors.All directors stand for election on an annual basis.                                                                                                                                                                                                                       |
| Majority Voting Uncontested Director Elections.Any director nominee must resign if they do notreceive an affirmative vote of a majority of votes castin an uncontested election. The Board will thendetermine whether to accept the resignation anddisclose any decision not to accept the resignation. |
| Director Independence.6 out of 7 director nominees are independent (alldirectors are independent other than the CEO;fully independent Audit and Finance Committee,Compensation and Talent ManagementCommittee and Nominating and CorporateGovernance Committee).                                        |

| Independent Board Leadership.Our Board of Directors maintains a Lead IndependentDirector who meets regularly with our independentmembers in executive session. |
| Board Refreshment.4 of our 6 independent Board nominees have joined inthe last 6 years and have expanded the Board’s scopeof experience.                       |
| Financial Literacy for Audit Committee.Three current Audit and Finance Committee membersare “